Evidence map›Paper›PMID 26171607›Full record

ArticlePloS one2015

Altered CSMD1 Expression Alters Cocaine-Conditioned Place Preference: Mutual Support for a Complex Locus from Human and Mouse Models.

Jana Drgonova, Donna Walther, Sulabh Singhal, Kennedy Johnson, Brice Kessler, Juan Troncoso, George R Uhl

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jana DrgonovaMolecular Nuropsychiatry Research Branch, NIH-IRP, NIDA, Baltimore, Maryland, United States of America.
Donna WaltherMolecular Nuropsychiatry Research Branch, NIH-IRP, NIDA, Baltimore, Maryland, United States of America.
Sulabh SinghalMolecular Nuropsychiatry Research Branch, NIH-IRP, NIDA, Baltimore, Maryland, United States of America.
Kennedy JohnsonMolecular Nuropsychiatry Research Branch, NIH-IRP, NIDA, Baltimore, Maryland, United States of America.
Brice KesslerMolecular Nuropsychiatry Research Branch, NIH-IRP, NIDA, Baltimore, Maryland, United States of America.
Juan TroncosoDivision of Neuropathology, Johns Hopkins School of Medicine, Baltimore MD, United States of America.
George R UhlOffice of Research & Development, New Mexico VA Healthcare System, Albuquerque, NM, United States of America.
Johns Hopkins Medicine · USNew Mexico VA Health Care System · US

Funding

Genetic Approaches To Characterizing Drug Responses And Vulnerabilities: MiceZIADA000165 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI UHL, GEORGE RICHARD · 2009 to 2016
$7.9M
Intramural NIH HHS Z99 DA999999
6 · The paper itself

Abstract

The CUB and sushi multiple domains 1 (CSMD1) gene harbors signals provided by clusters of nearby SNPs with 10-2 > p > 10-8 associations in genome wide association (GWAS) studies of addiction-related phenotypes. A CSMD1 intron 3 SNP displays p < 10-8 association with schizophrenia and more modest associations with individual differences in performance on tests of cognitive abilities. CSDM1 encodes a cell adhesion molecule likely to influence development, connections and plasticity of brain circuits in which it is expressed. We tested association between CSMD1 genotypes and expression of its mRNA in postmortem human brains (n = 181). Expression of CSMD1 mRNA in human postmortem cerebral cortical samples differs 15-25%, in individuals with different alleles of simple sequence length and SNP polymorphisms located in the gene's third/fifth introns, providing nominal though not Bonferroni-corrected significance. These data support mice with altered CSMD1 expression as models for common human CSMD1 allelic variation. We tested baseline and/or cocaine-evoked addiction, emotion, motor and memory-related behaviors in +/- and -/- csmd1 knockout mice on mixed and on C57-backcrossed genetic backgrounds. Initial csmd1 knockout mice on mixed genetic backgrounds displayed a variety of coat colors and sizable individual differences in responses during behavioral testing. Backcrossed mice displayed uniform black coat colors. Cocaine conditioned place preference testing revealed significant influences of genotype (p = 0.02). Homozygote knockouts displayed poorer performance on aspects of the Morris water maze task. They displayed increased locomotion in some, though not all, environments. The combined data thus support roles for common level-of-expression CSMD1 variation in a drug reward phenotype relevant to addiction and in cognitive differences that might be relevant to schizophrenia. Mouse model results can complement data from human association findings of modest magnitude that identify likely polygenic influences.

Indexed as

AnimalsCocaineCocaine-Related DisordersCognitionConditioning, PsychologicalFemaleGene Expression RegulationGene Knockout TechniquesGenetic LociHumansLocomotionMaleMaze LearningMembrane ProteinsMemoryMiceCocaineCSMD1 protein, humanCSMD1 protein, mouseMembrane ProteinsTumor Suppressor Proteins

Identifiers

PMID26171607
PMCPMC4501703
OpenAlexW2220260057

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.